Iron + Folic Acid (IFA) tablets/Capsule bulk supplier for pharma manufacturers

Iron + Folic Acid (Ifa) Tablets/Capsule Suppliers & Bulk Manufacturers

Available Forms: Tablet/Capsules

Available Strengths: 65 mg elemental iron + 400 mcg folic acid per tablet

Reference Brands: Numerous generic formulations

Category: Medical Aid

Iron + Folic Acid (IFA) tablets/Capsule is available in Tablet/Capsules and strengths such as 65 mg elemental iron + 400 mcg folic acid per tablet. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Iron + Folic Acid (IFA) tablets/Capsule is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Technical Specifications & Supply Details
Lead Time 7 to 60 days (depending on batch size & schedule)
MOQ As per manufacturer’s batch size
COA Available with every batch
Regulatory Dossier / DMF Available upon request
Export Documentation FSC, COA, Manufacturing License, Product Permission
Standards IP, BP, USP
Certifications WHO-GMP, EU-GMP, USFDA (as applicable)

Iron + Folic Acid (IFA) tablets/Capsule can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Product Description:

Iron plus Folic Acid (IFA) tablets are approved in the EU and US, supported by comprehensive dossiers demonstrating safety, efficacy, and quality in compliance with GMP standards. In the US, these supplements are often marketed as OTC products or prescription formulations with detailed FDA-reviewed dossiers. In the EU, they are available as both branded and generic products, with regulatory approval based on clinical data and manufacturing compliance. For detailed information on licensing, approved dossiers, and regulatory pathways for IFA tablets, visit Pharmatradz. Stay informed on the latest regulatory updates and market access requirements for iron and folic acid supplements globally.

Frequently Asked Questions

Yes, Iron + Folic Acid (IFA) tablets/Capsule is available with DMF and other regulatory documents such as COA and MSDS. These can be provided upon request for qualified buyers.

Absolutely. Sample requests are accepted for formulation trials and quality checks. Please submit an enquiry to initiate the process.

Our manufacturing partners are GMP-certified and comply with ISO and WHO standards, ensuring global quality benchmarks.

Lead times vary based on quantity and destination, but most orders are fulfilled within 1–3 weeks. Express shipping options are available.

Yes, Iron + Folic Acid (IFA) tablets/Capsule is exported to over 30 countries across Asia, Africa, Europe, and Latin America. We support documentation for customs and regulatory clearance.

Related Products

Chlorhexidine Solutions

Strength:
0.12% or 2%

Form: Solutions for disinfection

Reference Brands: Peridex, Periogard(US)

View Details
Hydrochlorothiazide Tablets

Strength:
12.5 mg, 25 mg, 50 mg

Form: Tablet

Reference Brands: Microzide, HydroDiuril(US)

View Details
Lisinopril Tablets

Strength:
2.5 mg, 5 mg, 10 mg, 20 mg, 40 mg

Form: Tablet

Reference Brands: Prinivil, Zestril(US & EU)

View Details
Enalapril Tablets

Strength:
2.5 mg, 5 mg, 10 mg, 20 mg

Form: Tablet

Reference Brands: Vasotec(US)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.